| Name |
Maxalt RPD 10 mg oralni liofilizati |
| Marketing Authorisation Number |
HR-H-455098518 |
| Active Substance |
rizatriptanbenzoat |
| Composition |
jedan oralni liofilizat sadrži 14,53 mg rizatriptanbenzoata (što odgovara 10 mg rizatriptana). |
| Pharmaceutical Form |
oralni liofilizat |
| Manufacturer |
Merck Sharp & Dohme B.V., Haarlem, Nizozemska |
| Marketing Authorisation Holder |
Organon Pharma d.o.o., Slavonska Avenija 1c, Zagreb, Hrvatska |
| Marketing Authorisation Date |
09.08.2021 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/653 |
| Registration Number |
381-12-01/154-21-14 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ponovljivi recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
N02CC04 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
